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TASK GROUP DESCRIPTION 
Background 
The degree to which an individual organism maintains healthspan and lifespan is a function 
of complex interactions between genetic inheritance (“nature”), environment, including 
cultural inheritance (nurture) and stochastic events (“luck” or “chance”). This task group will 
focus upon the role of chance because it is so poorly understood and because it appears to be 
of major importance in the determination of individual variations in healthspan and lifespan 
within species. The major factor determining variations in healthspan and lifespan between 
species is genetic inheritance. Broader aspects of cellular and molecular mechanisms of 
biological aging will also be considered, given their importance for understanding the cellular 
and molecular basis of successful aging.  The task force will consider the cellular and 
molecular basis for nature, nurture and chance in healthspan and life span determination.   
 
On the basis of comparisons between identical and non-identical twins, geneticists have 
estimated that genes control no more than about a quarter of the inter-individual differences 
in lifespan (Herskind 1996). Twin studies of very old individuals, however, show substantially 
greater genetic contributions to Healthspan (McClearn 2004; Reed 2003). The environment 
clearly plays an important role in the length and the quality of life. Tobacco smoke, for 
example has the potential to impact upon multiple body systems in ways that appear to 
accelerate the rates at which those systems age (Bernhard 2007). 
 
To document the role of chance events on aging, one must rigorously control both the genetic 
composition of an organism and its environment. This has been done to a remarkable degree 
in a species of nematodes, Caenorhabditis elegans (Vanfleteren 1998). The results confirm 
hundreds of previous studies with a wide range of species, especially those with inbred 
rodents housed under apparently identical but less well controlled environments. One 
observes wide variations in lifespan in all these studies. For the C. elegans experiments, the 
distributions of lifespan fit best with two parameter or three parameter logistic models and 
not with the classical Gompertz model nor the Weibull model. 
 
Many mutations have been shown to substantially increase lifespan in C. elegans. It is of 
interest, however, that the ranges of the lifespan variations among such mutant strains 
overlap with those of wild type strains (Kirkwood 2002). Many of these long-lived mutant 
strains exhibit enhanced resistance to a variety of stressors, notably heat shock. It was 
therefore predicted that variable degrees of response to heat shock stress might form a basis, 
or a partial basis, for individual variations in longevity. An initial set of experiments 
demonstrated that is indeed the case, at least for a transgenic construct that includes the 
promoter of a small heat shock gene (Rea 2005). There was a very strong correlation between 
the response to a heat stress and longevity, with good responding worms living  
longer. Strikingly, this phenotype was not heritable. The progeny of a worm showing a strong 
heat stress reaction exhibited the broad distribution of lifespans shown by the starting 
population. The heat stress reaction was therefore stochastic. The nature of the chance events 
that determine the reaction remains unknown. They could be related to the intrinsic 
instability of the transgene, making it important to repeat such experiments utilizing 
endogenous genes as reporters of the response to heat shock and other stressors. It could be 
due to epigenetic drifts in gene expression, perhaps involving random changes in gene 
promoters or in the state of chemical modifications to histone proteins that coat 
chromosomes. Such changes have indeed been observed in aging human identical twins 
(Fraga 2005). While those changes have been interpreted as being driven by the environment, 
one cannot at present rule out random variations unrelated to environmental influences. 
 
Variations in gene expression in genetically identical organisms examined under 
environmentally identical conditions have also been attributable to intrinsic “noise” in 
fundamental molecular processes such as the transcription and translation of genes. Most such 
observations have been made using microorganisms (Elowitz 2002), but stochastic bursts of 
transcription have also been noted in mammalian cells (Raj 2006). Moreover, substantial 
variation in the levels at which genes are transcribed have shown to occur in mouse tissues, 
and that variation was shown to increase with age (Bahar 2006).   
 
Chance events are also of major significance in the determination of diseases of aging. For the 
case of cancer, mutations have been shown to be of major importance. A likely key to 
malignancy, however, is the chance event of suffering a mutation in a gene which, when 
mutated, now greatly enhances the general frequency of mutation. Such genes are referred to 
as “mutator genes” (Bielas 2006). Chance events can make the difference between life and 
death of individuals with coronary artery atherosclerosis, as mortality often follows the 
rupture of an atherosclerotic plaque, an event that is likely to be due, in part, to a chance 
event (a “trigger”) leading to the rupture (Falk 1992).  Moreover, some genetic interventions 
that have been introduced into model organisms (nematodes, mice) increase mean but not 
maximum life span and appear to rectangularize the life span curve.  A recent example is a 
mouse strain carrying extra copies of a tumor suppressor locus (Matheu 2007).  As expected, 
these mice are remarkably cancer free.  Of particular interest, though, their mean, but not 
maximum, life span was extended.  Does this locus, and similar interventions, rectangularize 
the life span curve by reducing random events? 
 
Initial Challenges to Consider 
• What experiments might be designed in model organisms to probe the role of variations 
of endogenous gene expression at birth in the determinations of the remarkable stochastic 
variations in life span among genetically identical organisms? 
• Which subset of endogenous genetic loci are major contributors to such stochastic 
variation? 
• Are these variations in gene expression attributable to specific molecular events, such as 
chemical modifications to DNA CpG islands or histones? 
• What are the molecular and biophysical mechanisms that lead to transcriptional bursts in 
gene expression? 
• Do cells within an individual organism differ in their susceptibility to stochastic 
fluctuations in gene expression?  For example, are post-mitotic neurons more or less 
susceptible than cells that are destined to die or cells that turn over?  
• Are there species-specific differences in the degree to which stochastic fluctuations in 
gene expression occur (in similar cell types)?   
• Has evolution shaped the above stochastic variations in gene expression, are they 
adaptive, and what are the selective pressures that led to such adaptations? How can one 
test the hypothesis that different degrees of stochastic variations in gene expression do in 
fact evolve and that they are adaptive? 
• To what extent do early environmental influences in developing humans (fetal, neonatal, 
childhood, pubertal) determine patterns of gene expression and patterns of aging in 
human subjects? 
• Do genetic interventions that increase mean but not maximum life span, and appear to 
rectangularize the life span curve, act by reducing random events?  Can we learn about 
the cellular and molecular bases for stochastic variation by testing the hypothesis that 
some of these interventions act by this mechanism (reducing stochastic variation)?    
• What are some candidate environmental agents and social influences responsible for such 
putative influences and how can their impacts upon the public health be measured? 
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TASK GROUP SUMMARY 
Summary written by Iris Tse, Graduate Student, Boston University 
 
I have cataracts, lose uphill races, get really sick when I catch the flu, girls no longer 
whistle when I pass by, my joints ache, and if you looked closely you’d see preclinical 
signs of the cancer that will kill me. 
 
How Old am I? 
 
All species of animals do not age at the same rate. Humans, inevitably, will have a longer 
lifespan than horses, which in turn, will have a longer lifespan than most rodents. However, 
there is an unexpected synchronicity in the way age-related diseases appear across different 
species. At certain points in life, all of these animals will get vision degeneration, cancer, 
diabetes, CNS degeneration and organ failures. Even more surprising is that most of these age-
related diseases will appear in the similar sequence, regardless of lifespan and size of the 
animals. It appears as if some yet unknown species- or breed-specific factors are tying 
together these functional changes. Therefore the group found this to be an area worth 
pursuing. 
 
The validity of the stochastic model 
 
Before settling on this topic, the multidisciplinary group first debated in earnest the validity 
of the stochastic model as a formative criterion for healthspan and lifespan. The stochastic 
model was initially assigned to the group by the conference organizers as a springboard for 
discussion. Previous research has found that there is a wide range of lifespan within 
genetically identical cohort. Therefore, there must be some ephemeral non-genetic factor that 
can influence the aging trajectory and lifespan. Aging is not a 100 per cent deterministic issue 
and undefined gaps in current knowledge still needs to be examined and studies.  
 
However, some members of the group felt that even though there are undefined gaps in 
current knowledge, it would be premature to attribute the entirety of this unknown area to 
the stochastic model. The stochastic model, while important, is not the complete answer.  
 
After an hour of vigorous discussion and scrutiny, the group leader, Jerry Shay, a professor of 
cell biology at UT Southwestern Medical Center, distilled the group’s thinking.  
 
“To think that aging is stochastic, and therefore not within our control, greatly diminishes the 
impact and window of ability to understand, change and manipulate the process of aging,” 
said Shay. 
 
Important topics surrounding lifespan and healthspan 
 
Once the group discarded the stochastic model, the group members were free to explore other 
facets of aging. Linda Miller, the US Executive Editor of Nature and the Nature Journals, 
sparked the next round of discussion by pointing out neuro-degeneration as an area worth 
exploring. Topics suggested by other members of the group included: cell regenerative 
capacity, cellular replication and control, broad spectrum genomic analysis of aging, the 
frequency of cancerous tumor seen in post-reproductive period and biomaterials used in 
current research.  
 
However, the topic that seized the group’s attention was the synchronicity of age-associated 
decline. Richard Miller, a professor of pathology and geriatrics at the University of Michigan 
pointed out that many organs and cells fail at more or less the same time within a species. The 
sequence of illnesses are often synchronized across various species of animals, albeit at a 
different rate and adjusted to the expected lifespan of specific species. These co-morbid 
events, such as the onset of diabetes or cataracts, are not necessarily terminal illnesses and 
may not directly affect lifespan. However, they do have a huge effect on healthspan. If we can 
understand why humans get cataracts at 60-years-old and how mice get cataracts at 2-years-
old, we might be able to delay the onset of these symptoms, prolong healthspan and 
understand aging a little better.  
 Miller insisted that it will be useful to find themes, or common families, of underlying 
cellular or molecular factors that time aging sequentially. The initial goal will be to develop a 
new set of hypothesis for future experiments.  
 
Experimental approach 
 
Miller already had a rough idea of the experimental approach and the group spent the 
remaining day and half crystallizing those points. An important first step is to generate a list 
of late life dysfunctions plausibly related to the timing of aging. These age-related 
dysfunctions can be diseases, such as cancer, or symptoms, such as cataracts or cognitive 
failure, that affect many animals.  
 
Experts knowledgeable in aging or pathogenesis, or both, will be solicited to provide these 
hypotheses. They also will be called upon to brainstorm a body of known factors, such as 
proteins, macromolecules, enzymatic activities and genetic expressions that might influence 
the aforementioned list of diseases. By understanding the synchronicity of these factors, 
perhaps we will understand more about the synchronicity of aging.  
 
Since the group hoped to get the experiment started as quickly as possible, an important 
criterion to these hypotheses is that these factors must be easy and practical to measure using 
established methodology and reagents. A protocol using existing technology and knowledge 
of animals or research process will be favored over developing a novel process from scratch. 
For examples, we can look at cellular events such as ubiquitiation (or other regulatory factors 
or non-coding sequences), that doesn’t require species-specific antibodies.  
 
“Basically, you would want to be able use preexisting reagents or kits straight from a Sigma 
catalogue. Otherwise, you’d get mired over things like the trial and error of a new 
experimental design,” said Chris Patil, a postdoctoral scholar of life sciences from Lawrence 
Berkeley National Laboratory.  
 
The next step will be to select the proper animal models for interspecies comparison. The 
experiments will use healthy young adults with no age-related diseases because the selective 
factors that mold maturation is not the same as aging. These animals will be evaluated to 
uncover patterns of protein expressions, or possibly some other cellular events, that 
determine the rate of aging of that particular species. 
 
Four types of animals were chosen for this large-scale study: 
 
Primates – for their similarity to humans 
Bats – in most animals, lifespan is directly correlated to body weight. However, bats have a 
long lifespan for their small body size, therefore allowing researchers to observe trends 
that are actually related to lifespan and not weight.   
Rodents – lifespan varies drastically across different species of rodents, ranging from 2 years 
for mice to 30 years for naked mole rats. The variety allows experimenters to 
adjust for confounders. 
Birds – the non-mammalian outgroup to anchor the phylogenetic tree during statistical 
analysis. 
 
Additional funding will be necessary to trap and collect these animals, around ten species for 
each clade of animals. Animals from the wild will be ideal, since they provide a more realistic 
snapshot of the aging process. But, the group is also open to using captive animals, such as 
those from zoos, since this will hasten the process and likely to reduce cost.  
 
This broad-spectrum analysis is meant to generate useful hypotheses. It’s not meant to be a 
hypothesis-testing procedure. The end product from these experiments will produce 
information necessary to created mechanistic hypothesis for further testing. It is important to 
provoke further questions and examinations. Interspecies contrast will be the first step. Once 
something comes up as a hit, then the next step will be intraspecies comparison.  
 
“Instead of approaching diseases one at a time, which will take up too much time and it’s a 
narrow-minded way to do things,” said Miller. 
 
“This umbrella approach is a better way to probe the age/diseases nexus by exploiting the 
power of comparison.”  
 
 
